GlassScriptPhysician profile
Taylor Holmes
NPI 1548816457
$1,895.85
in general payments reported to CMS, 2019-2025
18 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.43 · 2022: $326 · 2023: $714 · 2024: $364 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $840 · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $839.61 |
| Food and Beverage | $708.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $855.26 | 2023-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| W. L. Gore & Associates, INC. | $242.62 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $191.33 | 2024 | Corevalve Evolut R, Valiant Captivia |
| Atricure, INC. | $176.54 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Arthrex, INC. | $103.06 | 2024 | |
| Merck Sharp & Dohme LLC | $72.88 | 2023-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $47.15 | 2022 | |
| Amgen INC. | $30.57 | 2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.90 | 2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $22.95 | 2023 | Optimizer |
| Novo Nordisk INC | $20.70 | 2024 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $18.04 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $16.71 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $15.92 | 2024 | |
| Kls-Martin L.P. | $15.32 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.79 | 2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $14.27 | 2023 | |
| Janssen Pharmaceuticals, INC | $12.84 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.